Modified Process Hepatitis B Vaccine in Japanese Young Adults (V232-062)

NCT01463683 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

722

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B

Interventions

BIOLOGICAL: 2XP HEPTAVAX™-II SC
BIOLOGICAL: 1XP HEPTAVAX™-II SC
BIOLOGICAL: 2XP HEPTAVAX™-II IM

Sponsor

Merck Sharp & Dohme LLC